Skip to main content
Fig. 1 | BMC Urology

Fig. 1

From: Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy

Fig. 1

Immunohistochemical staining of paraffin-embedded sections immediately before neoadjuvant chemotherapy with an anti-DYRK2 antibody. DYRK2 protein expression was localized within the cytoplasm. Magnification × 600. a DYRK2-negative staining pattern (no staining: score 0). b DYRK2-negative staining pattern (weak: score 1). c DYRK2-positive staining pattern (moderate: score 2). d DYRK2-positive staining pattern (strong: score 3)

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us